Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity." Fojo, Tito, Sham Mailankody and Andrew W. Lo. JAMA Otolaryngology Head Neck Surgery Vol. 140, No. 12 (2014): 1225-1236.
Parallel Discovery of Alzheimer's Therapeutics." Lo, Andrew W., Carole Ho, Jayna Cummings and Kenneth S. Kosik. Science Translational Medicine Vol. 6, No. 241 (2014): 241cm5.
Dealing with Femtorisks in International Relations." Frank, Aaaron Benjamin, Margaret Goud Collins, Simon A. Levin, Andrew W. Lo, Joshua Ramo, Ulf Dieckmann, Victor Kremenyuk, Arkady Kryazhimskiy, JoAnne Linnerooth-Bayer, Ben Ramalingam, J. Stapleton Roy, Donald G. Saari, Stefan Thurner and Detlof von Winterfeldt. Proceedings of the National Academy of Sciences Vol. 111, No. 49 (2014): 17356-1736.
The Origin of Risk Aversion." Zhang, Ruixun, Thomas J. Brennan and Andrew W. Lo. Proceedings of the National Academy of Sciences Vol. 111, No. 50 (2014): 1-6.
Group Selection as Behavioral Adaptation to Systematic Risk." Zhang, Ruixun, Thomas J. Brennan and Andrew W. Lo. PLoS ONE Vol. 9, No. 10 (2014): e110848.
A Survey of Systemic Risk Analytics." Bisias, Dimitrios, Mark Flood, Andrew W. Lo and Stavros Valavanis. Annual Review of Financial Economics Vol. 4, No. 1 (2012): 255-296.
